BioCryst Pharmaceuticals

BioCryst announces CEO succession plan

Published in Healthcare Finance, Tax and Law Weekly, October 18th, 2006

BioCryst Pharmaceuticals, Inc., (BCRX) announced that Charles E. Bugg, PhD, the company's chairman, CEO and co-founder, has informed the BioCryst board of directors that he intends to retire in 2007.

Bugg will retain his current duties as CEO until a replacement has taken office, at which time he will become non-executive chairman of BioCryst. A board sub-committee, to be chaired by Beth C. Seidenberg, MD, Partner at Kleiner Perkins Caufield & Byers, and including Zola P. Horovitz, PhD, lead director of BioCryst and former VP, Business Development and Planning at Bristol-Myers Squibb Co. and William W. Featheringill, president and CEO of Private Capital Corp., will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2006-10-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry